SCHEMBL5320129

SCHEMBL5320129

Fc1cc(F)cc(-c2cnc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)n3c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 5/20 0.46
AKT2 P31751 5/20 0.46
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
PTGS2 P35354 1/20 0.38
SLC2A1 P11166 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
LMNA P02545 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.35
NPC1 O15118 1/20 0.34
GRM5 P41594 4/20 0.34
PKM P14618 1/20 0.34
SLC2A3 P11169 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5341386 0.90 AKT1 (0.49) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5324372 0.88 AKT1 (0.55) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5354165 0.85 AKT1 (0.44) AKT1AKT2PTGS2MAPK13MAPK12
SCHEMBL5321674 0.82 AKT1 (0.45) AKT1AKT2RAB9AMAPK13MAPK12
SCHEMBL5325683 0.82 AKT1 (0.51) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5321323 0.82 AKT1 (0.50) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5320666 0.79 MAPK14 (0.43) AKT1AKT2PTGS2MAPK13MAPK12
SCHEMBL5322231 0.79 AKT1 (0.48) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5349048 0.79 AKT1 (0.48) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5338540 0.79 AKT1 (0.46) AKT1AKT2RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO claimed
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed